What is Dice Beauty: Roguelike Tactics?
Stop scrolling and check out Dice Beauty: Roguelike Tactics. It's a sharp blend of dice management and elemental strategy that pits you against powerful heroines in a tight tactical loop.
Gameplay
You're diving into a mix of deckbuilding and dice-based combat where you fight elemental heroines instead of the usual fantasy mobs. The core loop is all about managing your dice rolls to trigger elemental effects; you'll spend your turns stacking buffs and timing rolls to melt enemies. It's got that 'one more turn' energy similar to Balatro, though you won't find combos that break the game quite as hard. Run variety stays fresh because the elemental matchups force you to pivot your strategy on the fly.
Meta-progression is pretty lean here. You aren't grinding for permanent stat boosts like you would in Monster Train; instead, the focus is on how you modify your dice and build your deck during a single run. It's a tighter, more tactical experience, but it's definitely in Early Access. You'll run into a clunky UI during battles, and the elemental interactions have a steep learning curve. You'll probably lose your first couple of runs just trying to figure out how the systems actually talk to each other.
At $4.99, it's a cheap entry point for a tactical roguelike. It doesn't redefine the genre, borrowing heavily from the dice-roguelike playbook, but it adds a layer of tactical positioning that keeps it from feeling like a clone. If you can get past the rough edges of the EA state, the synergy loop is rewarding.
Key Features
- Dice-driven elemental combat
- Tactical positioning against heroines
- In-run dice and deck modification
- Risk management via dice rolls
Screenshots
Verdict
Grab this if you love tactical combat and don't mind some RNG for five bucks. If you want massive power creep or a polished, bug-free UI, wait until it leaves Early Access. 7.5/10.
View on Steam →* Price at time of publication (checked 25.06.2026). Prices may vary by region and are subject to change. This is an editorial review, not a commercial offer.